全文获取类型
收费全文 | 1829篇 |
免费 | 116篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 60篇 |
儿科学 | 71篇 |
妇产科学 | 73篇 |
基础医学 | 145篇 |
口腔科学 | 90篇 |
临床医学 | 198篇 |
内科学 | 392篇 |
皮肤病学 | 76篇 |
神经病学 | 176篇 |
特种医学 | 111篇 |
外科学 | 244篇 |
综合类 | 27篇 |
一般理论 | 1篇 |
预防医学 | 77篇 |
眼科学 | 61篇 |
药学 | 69篇 |
中国医学 | 10篇 |
肿瘤学 | 78篇 |
出版年
2024年 | 1篇 |
2023年 | 33篇 |
2022年 | 25篇 |
2021年 | 62篇 |
2020年 | 57篇 |
2019年 | 71篇 |
2018年 | 67篇 |
2017年 | 76篇 |
2016年 | 67篇 |
2015年 | 83篇 |
2014年 | 90篇 |
2013年 | 117篇 |
2012年 | 161篇 |
2011年 | 144篇 |
2010年 | 76篇 |
2009年 | 79篇 |
2008年 | 141篇 |
2007年 | 130篇 |
2006年 | 119篇 |
2005年 | 123篇 |
2004年 | 99篇 |
2003年 | 61篇 |
2002年 | 32篇 |
2001年 | 11篇 |
2000年 | 7篇 |
1999年 | 6篇 |
1998年 | 5篇 |
1997年 | 3篇 |
1996年 | 5篇 |
1995年 | 3篇 |
1994年 | 1篇 |
1992年 | 1篇 |
1989年 | 1篇 |
1986年 | 1篇 |
1977年 | 1篇 |
排序方式: 共有1959条查询结果,搜索用时 46 毫秒
1.
2.
3.
Ali Cetinkaya Kaniye Aydin Hatice A. Sirakaya Rumeysa Yilmaz 《Saudi medical journal》2020,41(12):1364
Loxosceles reclusa (L.reclusa) is known to bite humans, and its venom includes several enzymes that cause clinical symptoms. Loxoscelism, a condition due to being bitten by Loxosceles spiders, commonly known as recluses, can involve a range of clinical conditions, from local cutaneous lesions to severe systemic involvement. The diagnosis of loxoscelism is usually made by anamnesis and clinical findings. Magnetic resonance imaging is recommended for patients at high risk of necrotizing fasciitis. Treatment modalities are still controversial and there is no standardized treatment approach. Reported here, our case of loxoscelism involved a 24-year-old man presenting with a Loxosceles spider bite, dermonecrotic lesion, vomiting, diarrhea, acute renal injury, and rhabdomyolysis, who was successfully treated with hyperbaric oxygen therapy, therapeutic apheresis, hemodialysis, wound debridement, and cutaneous autografting. Early diagnosis and multidisciplinary approach can be life-saving in spider bites that can cause systemic involvement. Loxoscelism should be considered in patients with skin necrosis, acute renal injury, and rhabdomyolysis. 相似文献
4.
5.
6.
7.
8.
9.
Senem Maral Muradiye Acar Ozlem Sahin Balcik Eyyup Uctepe Omer Faruk Hatipoglu Derya Akdeniz Hatice Uludag Altun Ali Kosar Mehmet Gunduz Esra Gunduz 《Medicine》2015,94(16)
Chronic myeloproliferative disorders such as polycythemia vera (PV), essential thrombocytosis (ET), and idiopathic myelofibrosis arise from clonal proliferation of neoplastic stem cells in the bone marrow. Matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases that have potential to degrade all types of extracellular matrix (ECM) and also play a role in remodeling of the ECM. It is known that MMPs play a role in bone marrow remodeling.The primary goal of our study is to explore the relationship between chronic myeloproliferative diseases and some of MMP gene polymorphisms. The demonstration of a relationship will help to understand whether these polymorphisms may be a potential early diagnosis marker of the diseases.Patients were selected from outpatient clinics of Turgut Ozal University Hospital, Ankara, Turkey, between December 2010 and May 2011. Twenty-eight patients that previously diagnosed and followed-up with PV, 17 with secondary polycythemia (SP), and 12 with ET were enrolled in the study, along with a control group of 22 healthy people.DNA was isolated from peripheral blood. Using polymerase chain reaction–restriction fragment length polymorphism method, MMP2 and MMP9 gene polymorphisms were analyzed with agarose gel electrophoresis. There was a statistically significant difference between the study groups and the control group in terms of Gln279Arg polymorphisms rates of MMP9. The highest MMP9 Gln279Arg polymorphism rate was observed in the ET group. But nobody from the control group had polymorphic MMP9. There was no statistically significant difference between the groups in terms of MMP2-735 C > T polymorphism rates.In conclusion, MMP9 gene Gln279Arg polymorphism was associated with ET, SP, and PV diseases. Hence, we believe that these gene polymorphisms may play a role in the mechanism of bone marrow fibrosis and may be a factor that increases the risk of thrombosis. Illumination of the molecular basis of the relationship between MMP-thrombosis and MMP-fibrosis provides a better understanding of the pathophysiology of PV and ET diseases and will allow new approaches to diagnosis and treatment. 相似文献
10.
Sabri Tekin Hatice Özdoğan Mustafa Kemal Demir Hagar Soultan Sadia Zafar 《Transplantation proceedings》2021,53(4):1207-1210
Immunocompromised populations are at great risk of the current 2020 global emergency of coronavirus disease 2019 (COVID-19), and treatment of kidney transplant recipients with COVID-19 is currently not declared. Hence, the purpose of the study is to set a clear treatment regimen. We report here a therapeutic course of 2 patients who underwent transplant surgery in March 2020 and got infected soon after. Since the transplant, these 2 patients have received triple maintenance immunosuppressive therapy with oral tacrolimus, mycophenolate mofetil (MMF), and prednisone, and they have been regularly followed up at our hospital. The tacrolimus trough level was between 10 and 12 ng/mL. After the diagnosis of COVID-19, MMF was stopped and the tacrolimus dose was reduced so that blood level was between 4 and 6 ng/mL. The first patient was a 30-year-old man who, despite being treated with hydroxychloroquine, favipiravir, oseltamivir, and azithromycin therapy, died because of the presence of other comorbidities. The second case was a 58-year-old man who fully recovered from COVID-19 pneumonia with treatment with methylprednisolone, MMF, azithromycin, favipiravir, hydroxychloroquine, and reduction in immunosuppression dosage. This reflects the importance of using glucocorticoids in the treatment of COVID-19 along with other medications and the decreased mortality rate associated with their use. 相似文献